2014
DOI: 10.2337/db14-0331
|View full text |Cite
|
Sign up to set email alerts
|

The Extracellular Matrix Protein MAGP1 Is a Key Regulator of Adipose Tissue Remodeling During Obesity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 14 publications
1
4
0
Order By: Relevance
“…In accordance with data revealing the crucial role of ECM in AT physiology [37], we demonstrated that atECM can alter differentiation of ASCs. Previous reports showing that atECM coating stimulates osteogenesis of BM-MSCs [38] and that atECM-based scaffold stimulates chondrogenic differentiation of ASCs [39] are partly in contrast with our results as we showed that atECM inhibit osteogenic without change of chondrogenic capacity in ASCs.…”
Section: Discussionsupporting
confidence: 91%
“…In accordance with data revealing the crucial role of ECM in AT physiology [37], we demonstrated that atECM can alter differentiation of ASCs. Previous reports showing that atECM coating stimulates osteogenesis of BM-MSCs [38] and that atECM-based scaffold stimulates chondrogenic differentiation of ASCs [39] are partly in contrast with our results as we showed that atECM inhibit osteogenic without change of chondrogenic capacity in ASCs.…”
Section: Discussionsupporting
confidence: 91%
“…Several authors have shown the relationship between ECM remodeling and metabolic disturbances in obesity. Previous studies have demonstrated that several components of ECM are increased in individuals with obesity . In this sense, collagen VI‐null ob/ob mice showed better metabolic control when fed on HF diet allowing a better expansion of adipocytes.…”
Section: Discussionmentioning
confidence: 91%
“…MAGP-1 has been linked with complex phenotypes in multiple organ systems [18][19][20][21]. In this sense, Mfap2-deficient mice exhibited a phenotype of increased adiposity and impaired thermoregulation consistent with predisposition to metabolic dysfunction and increased TGF-β activity [22][23][24]. The treatment of Mfap2 knockout mice with antibodies neutralizing TGF-β prevented increased adiposity, proposing its role in the regulation of TGF-β in obesity and its associated comorbidities [17].…”
Section: Introductionmentioning
confidence: 99%